RA0371

antibody from Oursmab

Targeting: IL27 IL-27, IL-27A, IL27A, IL27p28, IL30, MGC71873, p28

Western blot (Data presented on provider website)

ELISA (Recommended by provider)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0371

Provider

Oursmab

Product name

Casdozokitug (Biosimilar Reference Antibody) (IL27)

Antibody type

Monoclonal

Description

Casdozokitug (CHS-388) is a potential first-in-class, human monoclonal antibody drug developed by Coherus BioSciences in the United States. As an immunotherapeutic agent, it is designed to modulate the tumor microenvironment by targeting a specific cytokine. Its primary mechanism involves blocking this cytokine's activity to alleviate immune suppression and thereby enhance the body's anti-tumor immune response.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.